WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Stock Ownership - Who owns Passage Bio?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Passage Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Orbimed Advisors LLC10% Owner2024-09-1939,300$0.71
$27.90kSell
Orbimed Advisors LLC10% Owner2024-09-1825,631$0.73
$18.71kSell
Orbimed Advisors LLC10% Owner2024-09-17111,400$0.73
$81.32kSell
Orbimed Advisors LLC10% Owner2024-09-1663,100$0.74
$46.69kSell
Mark S. FormanCHIEF MEDICAL OFFICER2024-02-131,638$0.97
$1.59kSell
Kathleen BorthwickSVP INTERIM CFO2024-02-131,470$0.97
$1.43kSell
Kathleen BorthwickSVP Interim CFO2024-01-0210,672$0.91
$9.71kSell
Mark S. FormanChief Medical Officer2024-01-0215,813$0.91
$14.39kSell
Edgar B. CaleGC Corporate Secretary2024-01-0215,813$0.91
$14.39kSell

1 of 1

PASG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PASG insiders and whales buy or sell their stock.

PASG Shareholders

What type of owners hold Passage Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC22.25%13,741,892$8.11MInsider
Orbimed Advisors LLC16.39%10,124,576$5.97MInstitution
Lynx1 Capital Management LP13.64%8,426,955$4.97MInsider
Vestal Point Capital LP9.80%6,052,000$3.57MInstitution
Lynx1 Capital Management LP8.19%5,057,629$2.98MInstitution
Frazier Life Sciences Ix LP8.11%5,009,219$2.96MInsider
Patrick J. Heron8.11%5,009,219$2.96MInsider
Versant Venture Capital Vi LP8.03%4,959,769$2.93MInsider
Thomas Woiwode8.03%4,959,769$2.93MInsider
Versant Venture Management LLC6.52%4,026,417$2.38MInstitution

1 of 3

PASG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PASG44.78%55.22%Net SellingNet Selling
FBIO15.89%56.29%Net BuyingNet Buying
LTRN11.95%65.14%Net SellingNet Selling
RVPH22.94%35.82%
CLNN11.21%88.79%Net BuyingNet Buying
View Top Biotech Stocks

Passage Bio Stock Ownership FAQ

Who owns Passage Bio?

Passage Bio (NASDAQ: PASG) is owned by 61.23% institutional shareholders, 75.52% Passage Bio insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Passage Bio shareholder, owning 13.74M shares representing 22.25% of the company. Orbimed Advisors LLC's Passage Bio shares are currently valued at $8.25M.

If you're new to stock investing, here's how to buy Passage Bio stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.